Health Condition 1: F411- Generalized anxiety disorder
Conditions
Sponsors
TerraBlue XT(P) Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subject is willing and able to give informed consent for participation in the study. 2.Subjects with DSM 5 clinical diagnosis of unipolar depression mood and GAD 3.Severity of anxiety and depression confirmed by PHQ-9 and GAD-7. 4.Male or Female of age 18 â?? 60 years
Exclusion criteria
Exclusion criteria: 1.Subjects with other psychotic disorders 2.Any neurological disorders such as any significant head injury, epilepsy, Parkinsonâ??s disease, neuro-degenerative disorders etc. 3.Subjects of substance use disorders 4.Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To validate the AI powered wearable device algorithm for detecting Generalized Anxiety Disorder (GAD) and Depressive Disorder (unipolar and recurrent depressive disorder) with a minimum acceptable sensitivity rate of 80% and specificity rate of 70 %.Timepoint: Screening or Baseline Visit | — |
Secondary
| Measure | Time frame |
|---|---|
| To validate whether technology can be used reliably for screening of common mental health disorders, like anxiety and depressionTimepoint: Screening or Baseline Visit | — |
Countries
India
Contacts
Public ContactPriya Ranjan Pattanaik
TerraBlue XT
Outcome results
None listed